Major histocompatibility complex class i and class II alleles may confer susceptibility to or protection against morphea: Findings from the morphea in adults and children cohort

Medicine & Life Sciences

• Localized Scleroderma 100%
• Major Histocompatibility Complex 72%
• Alleles 51%
• Child 30%
• HLA-B37 Antigen 10%
• National Institute of Arthritis and Musculoskeletal and Skin Diseases (U.S.) 10%
• Odds Ratio 9%
• Rheumatoid Arthritis 8%
• HLA-A Antigens 6%
• Confidence Intervals 6%
• Systemic Scleroderma 5%
• Rheumatology 5%
• National Institutes of Health (U.S.) 5%
• Case-Control Studies 4%
• Registries 4%
• Population 3%
• DNA 2%
• Health 2%